Immune Checkpoint Inhibitor-Associated Myocarditis: A Retrospective Case Series
{{output}}
Background: Immune checkpoint inhibitors (ICIs) improve outcomes across malignancies but can cause immune-related adverse events (irAEs), notably myocarditis, with case-fatality up to 50. ... ...
